Found 71 articles for: "Topical"
Nordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 949 | Copyright © October 2026
Background: Atopic dermatitis (AD) is a chronic disease with a dysfunctional skin barrier, requiring continuous management to reduce symptoms and prevent flares. Topical treatmen...
Read MoreA Narrative Review of Seven Off-Label Treatment Options for Seborrheic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 943 | Copyright © October 2026
Background: Seborrheic dermatitis (SD) is a chronic inflammatory skin condition driven by overactive sebaceous glands, Malassezia colonization, immune dysfunction, and epidermal ...
Read MoreThe Essential Role of Topical Targeted Therapy in Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 898 | Copyright © October 2026
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by immune dysregulation, epidermal barrier dysfunction, microbiome imbalance, pruritus, and xero...
Read MoreTopical Carboxytherapy as an Adjunct to Skin Recovery Post-CO2 Laser Fractional Resurfacing
September 2026 | Volume 25 | Issue 9 | Original Article | 839 | Copyright © September 2026
Background: Topical carboxytherapy, a transcutaneous carbon dioxide (CO2) delivery system, may support skin repair and regeneration, yet its role as an adjunct to fractional lase...
Read MoreTreatment Adherence in Patients With Acne Vulgaris: A Narrative Review
September 2026 | Volume 25 | Issue 9 | Original Article | 821 | Copyright © September 2026
Background: Acne vulgaris is a common dermatologic condition often requiring treatment using multiple mechanisms of action over a long time course to adequately clear symptoms. H...
Read MoreDecoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America
July 2026 | Volume 25 | Issue 7 | Original Article | 632 | Copyright © July 2026
Background: Sensitive skin syndrome (SSS) is a common self-reported condition, more prevalent in women, characterized by redness, irritation, and discomfort in response to variou...
Read MoreRacial Differences in Secondary Skin Complications and Timing of Topical Therapy Initiation for Pseudofolliculitis Barbae: A Multicenter Retrospective Database Cohort Study
July 2026 | Volume 25 | Issue 7 | Editorials | e69 | Copyright © July 2026
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
April 2026 | Volume 25 | Issue 4 | Editorials | e41 | Copyright © April 2026
Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema
March 2026 | Volume 25 | Issue 3 | Original Article | 228 | Copyright © March 2026
Background: Chronic hand eczema (CHE) is a common, heterogeneous inflammatory skin disease associated with substantial symptom burden, impaired hand function, reduced quality of ...
Read MoreAdvanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel
March 2026 | Volume 25 | Issue 3 | Original Article | 221 | Copyright © March 2026
Background: Advanced topical nonsteroidal therapies are expanding options for atopic dermatitis (AD) by providing targeted anti-inflammatory control without many limitations of l...
Read MoreScar Wars: A Review of Topical Scar Therapies
December 2025 | Volume 24 | Issue 12 | Features | 1265 | Copyright © December 2025
Visualization of Topical Roflumilast Versus Vehicle using Line-Field Optical Coherence Tomography in Healthy Skin
November 2025 | Volume 24 | Issue 11 | Original Article | 1126 | Copyright © November 2025
Background: Roflumilast is a topical phosphodiesterase-4 inhibitor FDA-approved for treating plaque psoriasis and atopic dermatitis. Line-field confocal optical coherence tomogra...
Read MoreCaffeine Supplementation and Hair: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1070 | Copyright © November 2025
Background: While caffeine has been proposed to stimulate hair growth, its safety and efficacy remain unclear. This systematic review evaluates the effects of caffeine interventi...
Read MoreManagement of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream
November 2025 | Volume 24 | Issue 11 | Case Reports | 1141 | Copyright © November 2025
Introduction: Benign Familial Pemphigus (Hailey-Hailey Disease [HHD]) is a rare chronic condition, with treatments focusing on managing disease symptoms.Case...
Read MoreSkin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin
October 2025 | Volume 24 | Issue 10 | Original Article | 1029 | Copyright © October 2025
Read MoreRuxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Original Article | 1036 | Copyright © October 2025
Atopic dermatitis (AD), a chronic inflammatory skin disease, is typically treated with topical corticosteroids in patients with mild to moderate disease, creating an ongoing need for nonsteroidal...
Read MoreUnderstanding Topical Steroid Withdrawal: Where Are We Now?
October 2025 | Volume 24 | Issue 10 | Features | 1057 | Copyright © October 2025
Eyelid Position and Patient-Reported Aesthetic Outcomes Following Administration of Topical Oxymetazoline: A Prospective Cohort Investigation
September 2025 | Volume 24 | Issue 9 | Original Article | 885 | Copyright © September 2025
Background: Topical oxymetazoline hydrochloride 0.1% is a pharmacologic agent for eyelid elevation.Objective: This study investigates changes in eye...
Read MoreSafety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne
August 2025 | Volume 24 | Issue 8 | Original Article | 803 | Copyright © August 2025
Background: Truncal acne is underdiagnosed and undertreated, and it can lead to scarring and postinflammatory hyperpigmentation. However, applying topical treatments to larger sk...
Read MorePrecision, Research, Progress: Updates in the Management of Pityriasis Rubra Pilaris
August 2025 | Volume 24 | Issue 8 | Features | 833 | Copyright © August 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
